The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results-Reference-Cited by-同舟云学术

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results

Published:2018-04-27 Issue:7 Volume:26 Page:984-995
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Bombard Yvonne,Clausen Marc,Mighton Chloe,Carlsson Lindsay,Casalino Selina,Glogowski Emily,Schrader Kasmintan,Evans Michael,Scheer Adena,Baxter Nancy,Hamilton Jada G.,Lerner-Ellis Jordan,Offit Kenneth,Robson Mark,Laupacis Andreas

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/s41431-018-0144-0.pdf

Reference49 articles.

1. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SFv2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249–55.

2. Fiallos K, Applegate C, Mathews DJH, Bollinger J, Bergner AL, James CA. Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease. Eur J Hum Genet. 2017;25:530–7.

3. Clift KE, Halverson CME, Fiksdal AS, Kumbamu A, Sharp RR, McCormick JB. Patients’ views on incidental findings from clinical exome sequencing. Appl Transl Genom. 2015;4:38–43.

4. Tan N, Amendola LM, O’Daniel JM, et al. Is “incidental finding” the best term?: a study of patients’ preferences. Genet Med. 2017;19:176–81.

5. Vears DF, Senecal K, Clarke AJ, et al. Points to consider for laboratories reporting results from diagnostic genomic sequencing. Eur J Hum Genet. 2018;26:36–43.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating ARAS with PyFWZIC to evaluate and benchmark patient-facing genetic services digital tools;Neural Computing and Applications;2024-07-22

2. Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing;2024-05-09

3. Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol;BMJ Open;2024-04

4. Evaluation of a two-step model of opportunistic genomic screening;European Journal of Human Genetics;2024-03-25

5. Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review;Cancer Medicine;2024-01-31